By Katherine Hamilton
Verint Systems beat Wall Street expectations with its first-quarter financial sales and adjusted earnings. Shares climbed 19% to $21.89 in postmarket trading Wednesday.
Liminatus Pharma said it regained compliance with Nasdaq listing requirements. It filed its delayed 10-Q on Monday after receiving a noncompliance notice on May 29. Shares jumped 72% to $21.88 after the market closed.
Five Below logged higher-than-expected sales in the first quarter, and said it expects its outperformance to continue into the second quarter. It raised its sales outlook for the full year, though new tariff costs are moderating other metrics. Shares advanced 4% to $125.75 after market close.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
June 04, 2025 19:32 ET (23:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。